论文部分内容阅读
目的观察重组人心钠肽治疗老年急性心力衰竭患者的临床疗效。方法对到本院就治的急性心力衰竭患者采取重组人心钠肽治疗,用药速率0.1μg/(kg·min),持续泵入1h。分别于用药前和后0.5h、1h、3h和12h测量患者的血流动力学参数并评价疗效。对照组给予硝酸甘油,起始剂量为10μg/(kg·min),根据血压情况,调整滴注速度,连用3d。结果治疗组患者有效率93.18%,对照组有效率65.91%。结论重组人心钠肽是治疗老年急性心力衰竭的有效药物。
Objective To observe the clinical efficacy of recombinant human atrial natriuretic peptide in elderly patients with acute heart failure. Methods Atrial natriuretic peptide was administered to patients with acute heart failure treated in our hospital at the rate of 0.1 μg / (kg · min) for 1 h. The hemodynamic parameters of the patients were measured at 0.5h, 1h, 3h and 12h before and after the treatment, and the curative effect was evaluated. The control group was given nitroglycerin, the initial dose of 10μg / (kg · min), according to the blood pressure, adjust the infusion rate, once every 3d. Results The effective rate was 93.18% in the treatment group and 65.91% in the control group. Conclusion Recombinant human atrial natriuretic peptide is an effective drug for the treatment of acute heart failure in the elderly.